MIRATI THERAPEUTICS, INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/84e309a3-92cc-4c52-a0d2-b11fdb8a145a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-740.9M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-005576 |
| FY 2021 | $-581.8M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-004246 |
| FY 2020 | $-357.9M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-003315 |
| FY 2019 | $-213.3M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002301 |
| FY 2018 | $-98.4M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002289 |
| FY 2017 | $-70.4M | 2017-01-01 – 2017-12-31 | evidence 0001628280-18-002942 |
| FY 2016 | $-83.1M | 2016-01-01 – 2016-12-31 | evidence 0001628280-17-002407 |
| FY 2015 | $-64.5M | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-012476 |
| FY 2014 | $-43.7M | 2014-01-01 – 2014-12-31 | evidence 0001628280-15-001687 |
| FY 2013 | $-52.9M | 2013-01-01 – 2013-12-31 | evidence 0001445305-14-001073 |
| FY 2012 | $-20.3M | 2012-01-01 – 2012-12-31 | evidence 0001445305-14-001073 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MIRATI THERAPEUTICS, INC. — all facts · Revenue · Operating Income